People - Office of the Coulter Program Director


Coulter Program Director

Scott Morley, MBA

Scott

Morley is a seasoned life sciences executive with broad experience in technology development, clinical trials, regulatory strategy, marketing, and sales.  He began his career at ALung Technologies, a Pittsburgh-based medical device company spun out from the University of Pittsburgh.  As ALung’s fourth employee, he quickly rose to become the lead engineer responsible for design and development of ALung’s artificial lung technology, the Hemolung RAS, which was originally developed in the lab of Bioengineering Professor William Federspiel. Morley went on to lead clinical studies in India and Germany resulting in global product approvals. Simultaneously, he built a new therapeutic market for the technology, establishing ALung’s leadership position through a strategy of clinical collaboration with global key opinion leaders and medical societies. After running a global product launch, Morley oversaw the start of ALung’s VENT-AVOID Trial, a 40-center pivotal IDE trial aimed at securing US FDA approval. Most recently, he founded 3Rivers MedTech LLC, providing innovation and commercialization services to the medtech industry. 

Morley is a two-time graduate of the University of Pittsburgh having earned a BS from the Swanson School of Engineering (Bioengineering) and an MBA from Katz Graduate School of Business (Marketing). In tandem with his duties as the Coulter@Pitt Program Director, Morley is also an Entrepreneur in Residence with the University of Pittsburgh Innovation Institute where he is supporting the commercialization of life science innovations with a focus on medical devices and diagnostics. 

Contact:

120 McKee Place
Pittsburgh, PA 15213

Email:scott.morley@pitt.edu
Office:412-624-0403

Coulter Program Assistant Director

Lindsay Rodzwicz, BS 

Lindsay

Email: rodzwicz@pitt.edu
Telephone: 412-624-3495 

Coulter Program Portfolio Manager

Shubhangi Lal, MBA

Shubhangi
Email: SHL88@pitt.edu

Telephone: 412-624-0100